Press Releases

Full Estetrol (E4) Program Update Provided at Scientific Advisory Board Meetings
19 November 2018
EN FR

Mithra Announces the Completion of its Lead Clinical Phase III Programme for Estelle®
14 November 2018
EN FR

New Warrant Plan Approved by Mithra Shareholders
6 November 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement with Adcock Ingram for Commercialization of Estelle® in Southern Africa
30 October 2018
EN FR

2018 Update and 2019 Outlook Given at the CPHI Conference
10 October 2018
EN FR

Notice of 2018 Extraordinary General Meeting Regarding Proposed Warrant Plan
5 October 2018
EN FR

Presentation of Donesta® PhIIb Results at the 2018 Annual Meeting of the North American Menopause Society
3 October 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for the Commercialization of Myring™ in Chile with Laboratorio Pasteur
27 September 2018
EN FR

Mithra Announces 2018 Half Year Results
25 September 2018
EN FR

Interim Financial Report as at 30 June 2018
25 September 2018
EN FR

Mithra Finalizes Contract for the Commercialization of Estelle® with South Korean Women’s Health Leader Hyundai Pharm
24 September 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for Commercialization of Tibelia® in Taiwan
21 September 2018
EN FR